2′3′-cyclic dinucleotides
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F21%3A00553242" target="_blank" >RIV/61388963:_____/21:00553242 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/patent/search/family/066440086/publication/US11149052B2?q=US11149052" target="_blank" >https://worldwide.espacenet.com/patent/search/family/066440086/publication/US11149052B2?q=US11149052</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
2′3′-cyclic dinucleotides
Original language description
The present disclosure relates to 2′3′-cyclic dinucleotides modified with a 2′- or 3′-phosphonoalkyl bond and derivatives thereof, that can modulate the activity of the STING adaptor protein.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
10401 - Organic chemistry
Result continuities
Project
<a href="/en/project/EF16_019%2F0000729" target="_blank" >EF16_019/0000729: Chemical biology for drugging undruggable targets</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
US11149052
Publisher
US001 -
Publisher name
United States Patent and Trademark Office (USPTO)
Place of publication
Alexandria
Publication country
US - UNITED STATES
Date of acceptance
Oct 19, 2021
Owner name
Ústav organické chemie a biochemie AV ČR, v. v. i
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence